{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:04:43Z","timestamp":1793862283092,"version":"4.6.1"},"reference-count":123,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2023,3,24]]},"DOI":"10.1080\/14656566.2023.2192349","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T18:30:11Z","timestamp":1678991411000},"page":"557-576","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["An evaluation of pharmacological options for Cushing\u2019s disease: what are the state-of-the-art options?"],"prefix":"10.1080","volume":"24","author":[{"given":"Marianna","family":"Martino","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences (DISCLIMO). Polytechnic University of Marche Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nairus","family":"Aboud","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences (DISCLIMO). Polytechnic University of Marche Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Lucchetti","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences (DISCLIMO). Polytechnic University of Marche Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmaria","family":"Salvio","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences (DISCLIMO). Polytechnic University of Marche Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6204-3423","authenticated-orcid":false,"given":"Giorgio","family":"Arnaldi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences (DISCLIMO). Polytechnic University of Marche Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,3,19]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0125"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030871"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0612"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1818"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00235-7"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3166"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2734"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1444606"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiotec.2015.02.032"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12068"},{"key":"cit0011","unstructured":"ClinicalTrials.gov: roscovitine [Internet]. [cited 2022 Apr 24]. Available from: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=roscovitine&cntry=&state=&city=&dist=accessed-on-29\/04\/2022."},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11098"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1820"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2328"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8173182"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1210\/js.2016-1053"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0689"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60417"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00101"},{"key":"cit0020","first-page":"1","volume":"158","author":"Feldhaus AL","year":"2017","journal-title":"Endocrinology"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1210\/me.2015-1241"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3776"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0607-4"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00464"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00267.2017"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1210\/en.2018-00588"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2295-8"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13951"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0251-5"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-2052"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-020-00899-1"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-15-0527"},{"key":"cit0033","unstructured":"ClinicalTrials.gov: a Study of ATR-101 for the Treatment of Endogenous Cushing\u2019s Syndrome [Internet]. [cited 2022 May 2]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03053271."},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00648"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031746"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30155-4"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0662"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1533"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.732240"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0936-7"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0807"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0475-3"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14123"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-1014"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101718"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0926-y"},{"key":"cit0047","unstructured":"FDA.gov: SIGNIFOR\u00ae LAR (pasireotide) for injectable suspension, for intramuscular use Initial U.S. Approval: 2012 [Internet]. [cited 2022 Apr 24]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/203255s008lbl.pdf."},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2010.495943"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-022-09710-3"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01876"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1008"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0503-3"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105743"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1316-3"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0978-6"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00436"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1818-7"},{"key":"cit0058","unstructured":"ClinicalTrials.gov: long term safety and efficacy of pasireotide s.c. in patients with cushing\u2019s disease [Internet]. [cited 2022 May 14]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02310269."},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-00984-6"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0539-4"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0582-9"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-101347"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12431"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0618-1"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-019-01021-2"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-012-0427-3"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01077-8"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01161-4"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0499-0"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-014-0557-x"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01055-x"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0483-3"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30326-1"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01246-0"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14081"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa778"},{"key":"cit0077","unstructured":"European medicines agency: ketoconazole HRA [Internet]. [cited 2022 Apr 24]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ketoconazole-hra."},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0897-z"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0514"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04424.x"},{"issue":"99","key":"cit0081","first-page":"1623","volume":"2014","author":"Castinetti F","journal-title":"J Clin Endocrinol Metab"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0886"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1021\/jm00093a015"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2021.1945440"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.05.021"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa989"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30313-4"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa046.1129"},{"key":"cit0089","unstructured":"ClinicalTrials.gov: open-label Treatment in Cushing\u2019s Syndrome (OPTICS) [Internet]. [cited 2022 Apr 24]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03621280."},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01103-6"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.595894"},{"key":"cit0092","unstructured":"ClinicalTrials.gov: a study to assess the safety and efficacy of levoketoconazole in the treatment of endogenous cushing\u2019s syndrome [Internet]. [cited 2022 Apr 24]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03277690."},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2616"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1675-4"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2011.011014"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa167"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01277-0"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2117"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-015-0692-z"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30240-0"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00217"},{"key":"cit0102","unstructured":"ClinicalTrials.gov: efficacy and safety evaluation of osilodrostat in cushing\u2019s disease (LINC-4) [Internet]. [cited 2022 Apr 24]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02697734."},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0557"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01097-1"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1177\/20420188211058583"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00269"},{"key":"cit0107","first-page":"6","volume":"2019","author":"Wong SWP","year":"2019","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0608"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0358"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0215"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3350"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1843"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-015-0059-5"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0098"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.389"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00162"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.662865"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3200"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1000094"},{"key":"cit0120","unstructured":"ClinicalTrials.gov: study of the efficacy and safety of pasireotide s.c. \u00b1 cabergoline in patients with cushing\u2019s disease [Internet]. [cited 2022 Apr 24]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT01915303."},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0536"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0913"},{"key":"cit0123","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-0352"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2023.2192349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T14:54:18Z","timestamp":1681397658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2023.2192349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,19]]},"references-count":123,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,3,24]]}},"alternative-id":["10.1080\/14656566.2023.2192349"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2023.2192349","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-12-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}